5-Fluorouracil-Induced Leukoencephalopathy: Report of Two Cases and Review of Literature

被引:0
|
作者
Supreeth, R. N. [1 ]
Hingmire, Sachin [1 ]
Joshi, Aniruddha [2 ]
机构
[1] Deenanath Mangeshkar Hosp, Dept Med Oncol, Pune, India
[2] Deenanath Mangeshkar Hosp, Radiol, Pune, India
关键词
5-fluorouracil; leukoencephalopathy; GI malignancies; neurotoxicity; MULTIFOCAL LEUKOENCEPHALOPATHY; TEGAFUR; THERAPY; CANCER;
D O I
10.1055/s-0044-1779488
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5-fluorouracil (5FU) forms an important component of chemotherapy regimens used in various gastrointestinal (GI) adenocarcinomas and head and neck squamous cell carcinomas. Leukoencephalopathy is a rare adverse effect of 5FU, mediated by hyperammonemia and hyperlactatemia. We report cases of two patients with GI adenocarcinomas who developed neurological symptoms while on 5FU infusion. The neuroimaging and biochemical parameters were suggestive of toxic leukoencephalopathy. They were managed with cessation of the drug and short-term antiepileptic therapy. We also discuss the pathophysiology of this adverse effect and its management.
引用
收藏
页码:546 / 549
页数:4
相关论文
共 50 条
  • [41] Progressive Multifocal Leukoencephalopathy - A Case Report and Review of the Literature
    Smolle, Elisabeth
    Trojan, Andreas
    Schuster, Stephen J.
    Haybaeck, Johannes
    IN VIVO, 2014, 28 (05): : 941 - 948
  • [42] The confused cancer patient: a case of 5-fluorouracil-induced encephalopathy
    Cheung, W. Y.
    Fralick, R. A.
    Cheng, S.
    CURRENT ONCOLOGY, 2008, 15 (05) : 234 - 236
  • [43] 5-Fluorouracil-Induced Tako-Tsubo-Like Syndrome
    Basselin, Cecile
    Fontanges, Thierry
    Descotes, Jacques
    Chevalier, Philippe
    Bui-Xuan, Bernard
    Feinard, Gwennaelle
    Timour, Quadiri
    PHARMACOTHERAPY, 2011, 31 (02): : 226 - 226
  • [44] Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis
    C. A. C. X. Medeiros
    R. F. C. Leitão
    R. N. Macedo
    D. R. M. M. Barboza
    A. S. Gomes
    N. A. P. Nogueira
    N. M. N. Alencar
    R. A. Ribeiro
    G. A. C. Brito
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1085 - 1100
  • [45] Protective effects of glutathione on 5-fluorouracil-induced myelosuppression in mice
    Kojima, S
    Takaba, K
    Kitmoto, N
    Takeda, T
    Kakuni, M
    Mizutani, M
    Suzuki, K
    Sato, H
    Hara, T
    ARCHIVES OF TOXICOLOGY, 2003, 77 (05) : 285 - 290
  • [46] Rifaximin modulates 5-fluorouracil-induced gastrointestinal mucositis in rats
    Ciobanu, L.
    Tantau, M.
    Valean, S.
    Parau, A.
    Bedecean, I.
    Mirleneanu, R.
    Berce, C.
    Catoi, C.
    Taulescu, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (23) : 4993 - 5001
  • [47] Saroglitazar ameliorates 5-Fluorouracil-induced hepatorenal damage in rats
    Alharbi, Alhomedy M.
    Kafl, Hoda E.
    Abdelaziz, Rania R.
    Suddek, Ghada M.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [48] EVALUATION OF 5-FLUOROURACIL-INDUCED CARDIOTOXICITY: ROLE OF CARDIAC BIOMARKERS
    Moghaddam, Zhaleh Karimi
    Rostami, Mina
    Zeraatchi, Alireza
    Abadi, Hamidreza Fallah
    Karamitanha, Farzaneh
    Amirmoghaddami, Hamidreza
    EXPERIMENTAL ONCOLOGY, 2022, 44 (01) : 60 - 66
  • [49] 5-Fluorouracil-induced hyperammonaemic encephalopathy: A French national survey
    Boileve, Alice
    Thomas, Laure
    Lillo-Le Louet, Agnes
    Gaboriau, Louise
    Chouchana, Laurent
    Ducreux, Michel
    Malka, David
    Boige, Valerie
    Hollebecque, Antoine
    Hillaire-Buys, Dominique
    Jozwiak, Mathieu
    EUROPEAN JOURNAL OF CANCER, 2020, 129 : 32 - 40
  • [50] Bleomycin-Induced Fulminant Hyperpyrexia: A Report of Two Cases and Review of Literature
    Jhatial, Mussadique Ali
    Bin Naeem, Sameen
    Abbas, Mansoor
    Baloch, Naqib Ullah
    Bokhari, Syed W.
    Ahsan, Bushra
    Ahmad, Usman
    Sheikh, Rizwan Masood
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)